239 related articles for article (PubMed ID: 16033968)
1. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.
Zhao Z; Date T; Li Y; Kato T; Miyamoto M; Yasui K; Wakita T
J Gen Virol; 2005 Aug; 86(Pt 8):2209-2220. PubMed ID: 16033968
[TBL] [Abstract][Full Text] [Related]
2. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
[TBL] [Abstract][Full Text] [Related]
3. Acidity/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice.
Zheng X; Zheng H; Tong W; Li G; Wang T; Li L; Gao F; Shan T; Yu H; Zhou Y; Qiu Y; Ma Z; Tong G
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158291
[TBL] [Abstract][Full Text] [Related]
4. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
6. A simple method for developing an infectious cDNA clone of Japanese encephalitis virus.
Zheng H; Zheng X; Tong W; Liu F; Liang C; Wang T; Gao F; Li L; Shan T; Li G; Tong G
Virus Genes; 2017 Feb; 53(1):4-14. PubMed ID: 27665292
[TBL] [Abstract][Full Text] [Related]
7. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability.
Wang X; Li SH; Zhu L; Nian QG; Yuan S; Gao Q; Hu Z; Ye Q; Li XF; Xie DY; Shaw N; Wang J; Walter TS; Huiskonen JT; Fry EE; Qin CF; Stuart DI; Rao Z
Nat Commun; 2017 Apr; 8(1):14. PubMed ID: 28446752
[TBL] [Abstract][Full Text] [Related]
8. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
9. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
Lee E; Lobigs M
J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
[TBL] [Abstract][Full Text] [Related]
11. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
12. An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus.
Du R; Wang M; Hu Z; Wang H; Deng F
Virol Sin; 2015 Oct; 30(5):354-62. PubMed ID: 26463213
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication.
Mori Y; Okabayashi T; Yamashita T; Zhao Z; Wakita T; Yasui K; Hasebe F; Tadano M; Konishi E; Moriishi K; Matsuura Y
J Virol; 2005 Mar; 79(6):3448-58. PubMed ID: 15731239
[TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice.
Nickols B; Tretyakova I; Tibbens A; Klyushnenkova E; Pushko P
Virology; 2017 Dec; 512():66-73. PubMed ID: 28938099
[TBL] [Abstract][Full Text] [Related]
15. Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells.
Mori Y; Yamashita T; Tanaka Y; Tsuda Y; Abe T; Moriishi K; Matsuura Y
J Virol; 2007 Aug; 81(16):8477-87. PubMed ID: 17553875
[TBL] [Abstract][Full Text] [Related]
16. Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A.
Li XD; Li XF; Ye HQ; Deng CL; Ye Q; Shan C; Shang BD; Xu LL; Li SH; Cao SB; Yuan ZM; Shi PY; Qin CF; Zhang B
J Gen Virol; 2014 Apr; 95(Pt 4):806-815. PubMed ID: 24362961
[TBL] [Abstract][Full Text] [Related]
17. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates.
Sumiyoshi H; Hoke CH; Trent DW
J Virol; 1992 Sep; 66(9):5425-31. PubMed ID: 1501281
[TBL] [Abstract][Full Text] [Related]
18. Full genome sequence and virulence analyses of the recent equine isolate of Japanese encephalitis virus.
Shimojima M; Nagao Y; Shimoda H; Tamaru S; Yamanaka T; Matsumura T; Kondo T; Maeda K
J Vet Med Sci; 2011 Jun; 73(6):813-6. PubMed ID: 21233594
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro.
Chen LK; Lin YL; Liao CL; Lin CG; Huang YL; Yeh CT; Lai SC; Jan JT; Chin C
Virology; 1996 Sep; 223(1):79-88. PubMed ID: 8806542
[TBL] [Abstract][Full Text] [Related]
20. Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.
Mathenge EGM; Parquet MDC; Funakoshi Y; Houhara S; Wong PF; Ichinose A; Hasebe F; Inoue S; Morita K
J Gen Virol; 2004 Sep; 85(Pt 9):2503-2513. PubMed ID: 15302944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]